Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.
Biotechnology company founded in 2015 that develops and commercializes synthetic lipid compounds and cancer immunotherapy agents. iOx Therapeutics is an OSI spinout.